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Abstract 
Growth factors such as thrombin and transforming Growth Factor (TGF)-β facilitate 
glycosaminoglycan (GAG) chain hyperelongation on proteoglycans , a phenomenon that 
increases lipoprotein binding in the vessel wall and the development of atherosclerosis. TGF -β 
signals via canonical carboxy terminal phosphorylation of R-Smads and also non-canonical 
linker region phosphorylation of R-Smads. The G protein coupled receptor agonist, thrombin, 
can transactivate the TGF-β receptor leading to both canonical and non-canonical Smad 
signalling. Linker region phosphorylation drives the expression of genes for the synthesis of 
the proteoglycan, biglycan. Proteoglycan synthesis involves core protein synthesis, the 
initiation of GAG chains and the subsequent elongation of GAG chains. We have explored the 
relationship between the thrombin stimulated phosphorylation of individual serine and 
threonine sites in the linker region of Smad2 and the expression of GAG initiation 
xylosyltransferase-1 (XT-1) and GAG elongation chondroitin 4-sulfotransferase-1(C4ST-1) 
and chondroitin synthase-1 (CHSY-1) genes. Thrombin stimulated the phosphorylation of all 
four target residues (Thr220, Ser245, Ser250 and Ser255 residues) with a similar temporal 
pattern – phosphorylation was maximal at 15 min (the earliest time point studied) and the level 
of the phospho-proteins declined thereafter  over the following 4 hours. Jnk, p38 and PI3K, 
selectively mediated the phosphorylation of the Thr220 residue whereas the serine residues 
were variously phosphorylated by multiple kinases. Thrombin stimulated the expression of all 
three genes – XT-1, C4ST-1 and CHSY-1. The three pathways mediating Thr220 
phosphorylation were also involved in the expression of XT-1. The target pathways (excluding 
Jnk) were involved in the expression of the GAG elongation genes (C4ST-1 and CHSY-1). 
These findings support the contention that individual Smad linker region phosphorylation sites 
are linked to the expression of genes for the initiation and elongation of GAG chains on 
proteoglycans. The context of this work is that a specific inhibitor of GAG elongation 
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represents a potential therapeutic agent for preventing GAG elongation and lipid binding and 
the results indicate that the specificity of the pathways is such that it might be therapeutically 
feasible to specifically target GAG elongation without interfering with other physiological 
processes with which proteoglycans are involved.  
Keywords: Transactivation signalling, G-protein coupled receptors, Smad, Smad linker region, G 
proteins, Serine/threonine kinase receptors  
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Abbreviations 
CDK cyclin dependent kinase  
CHSY-1 chondroitin synthase  
C4ST-1 chondroitin 4-O-sulfotranferase 
EGFR epidermal growth factor receptor  
GAG glycosaminoglycan  
GalT-1 β-1,3-galactosyl transferase-1  
GlcAT-1 β-1,3-glucuronosyl transferase-1  
GPCRs G protein coupled receptors 
MAPK mitogen activated protein kinase  
PI3K phosphatidylinositide 3-kinase  
PAR protease activated receptor  
PTKR protein tyrosine kinase receptors  
S/TKR serine/threonine kinase receptors  
TGF-β transforming growth factor beta  
TGFBR1 transforming growth factor beta receptor  
VSMCs vascular smooth muscle cells  
XT-1 xylosyltransferase 1 
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1. Introduction  
Transforming Growth Factor (TGF)-β is a pleiotropic growth factor with broad 
involvement in physiological and pathophysiological processes. TGF-β has a very strong effect 
to stimulate the hyperelongation of glycosaminoglycan (GAG) chains on the major lipid 
binding proteoglycan biglycan and as it is associated with lipid deposition in atherosclerosis 
then this process represents a potential therapeutic target [1, 2]. TGF-β signals via canonical 
carboxy terminal phosphorylation of R-Smads (Smad2 in vascular smooth muscle cells 
(VSMC)) and non-canonical linker region phosphorylation of R-Smads [3, 4]. The role of 
TGF-β signalling in cell biology was greatly expanded when we showed that the paradigm of 
G Protein Coupled Receptor (GPCR) transactivation of protein tyrosine kinase receptors 
extended to the transactivation of serine/threonine kinase receptors and specifically the Type I 
TGF-β Receptor (TGFBR1) [5-8].  
GPCRs such as Protease Activated Receptor (PAR) -1 and endothelin receptors can 
engage TGFBR1 and activate downstream signalling commencing with Smad phosphorylation 
[9-12]. The PAR-1 agonist thrombin can transactivate the TGFBR1 in VSMCS leading to both 
canonical and non-canonical Smad signalling and downstream effects on the synthesis, 
specifically elongation of the GAG chains on the lipid-binding chondroitin sulfate/dermatan 
sulfate (CS/DS) proteoglycan, biglycan. Proteoglycan synthesis is a complex process which 
involves core protein synthesis, the initiation of GAG chain synthesis and the subsequent 
elongation and maturity of GAG chains [13-17]. Whereas Smad linker region phosphorylation 
was initially described to inhibit Smad nuclear translocation [18] and hence TGF-β signalling, 
in an in vitro model of atherosclerosis we showed that linker region phosphorylation drives the 
expression of genes for the enzymes and transferases responsible for the synthesis of the 
biglycan [19-21]. 
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Chondroitin sulfate GAG chain synthesis commences with the synthesis of the tetra-
saccharide linkage region by the initial action of xylosyltransferase 1 (XT-1) [22] to transfer a 
xylose to the serine residue on the core protein, followed by the combined action of three 
enzymes β-1,3-galactosyl transferase-1 (GalT-1), GalT-2 and β-1,3-glucuronosyl transferase-1 
(GlcAT-1) to add two galactose and one glucuronic acid residues. GAG chain synthesis 
involves the combination of more than one GAG synthesizing enzyme for the elongation of the 
GAG chain. An increase in GAG chain length and an increase in atherosclerotic lesion 
progression in vivo is associated with an increase in GAG enzyme expression [23].   
The cell signalling mechanisms involved in GAG synthesis and elongation are distinct [6, 
24]. The canonical TGF-β signalling pathway comprises direct carboxy-terminal 
phosphorylation of Smad2 by TGFBR1. In addition, Smads can also be phosphorylated in the 
linker region [3, 4, 25, 26]. Smad linker region is phosphorylated via multiple serine/threonine 
kinases including mitogen activated protein kinase (MAPK) (Erk, Jnk and p38), 
phosphatidylinositide 3-kinase (PI3K) and cyclin dependent kinase (CDK) [19, 20, 27]. There 
are multiple phosphorylation sites in the human Smad2 linker region: threonine at position 220 
(Thr220) and three serine residues at positions 245, 250, 255 (Ser245, Ser250, Ser255) [3, 26]. 
TGF-β mediated GAG chain hyperelongation [20] and GAG synthesizing gene expression [19] 
are regulated by the Smad2 linker region. The role of Smad2 linker region phosphorylation in 
thrombin signalling has not been elucidated but it represents an interesting model to study the 
implications of TGFBR1 transactivation and the broader relationship between GPCRs and cell 
surface kinase receptor transactivation.  
The Smad2 linker region plays a central integrating point for GPCR mediated signalling 
for the expression of the genes for the enzymes, which mediate the initiation, and elongation 
of GAGs on proteoglycans. With the complexity of the synthesis of proteoglycans involving 
more than ten transferases and elongation factors, this is a suitable model to study the 
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relationship between the individual sites of phosphorylation of serine/threonine residues in the 
linker region of Smad2 and the resultant expression of specific genes for GAG initiation and 
elongation transferases.  
2. Materials and Methods 
2.1 Materials 
Foetal bovine serum (FBS) was purchased from Invitro Technologies Pty. Ltd. (VIC, 
Australia). Dulbecco’s Modified Eagle Medium (DMEM) (0mM and 25mM glucose), 
Trypsin-Versene, penicillin and streptomycin were from GIBCO BRL (Ne, USA). Human 
TGF-β, anti-rabbit IgG horseradish peroxidase (HRP), anti-GAPDH antibodies were purchased 
from Cell Signalling Technology (MA, USA). Flavopiridol, SP600125, SB202190 and 
LY294002 were purchased from Sigma-Aldrich (St Louis, USA). UO126 was from Promega 
(WI, USA). CHSY-1 rabbit polyclonal antibody was purchased from Abcam (Vic, Australia). 
C4ST-1 rabbit polyclonal antibody was purchased from ThermoFishes Scienctific (Vic, 
Australia). Amersham ECL Prime chemiluminescence detection reagent was purchased from 
GE Healthcare (Paramatta, Australia). The primers (forward and reverse) for C4ST-1, 
CHSY-1, XT-1, EXT-1, EXT-2, EXT-3, NDST-1 and 18S, RNeasy Mini Kit, the QuantiTect 
reverse transcription kit, QuantiFast SYBR green PCR kit and the Rotor Gene Q series software 
were from Qiagen (Vic, Australia). Anti-phospho-Smad2L(Thr220) rabbit IgG polyclonal, 
anti-phospho-Smad2L(Ser245) rabbit IgG polyclonal, anti-phospho-Smad2L(Ser250) rabbit 
IgG polyclonal and anit-phospho-Smad2L(Ser255) rabbit IgG polyclonal were a gift from 
Professor Koichi Matsuzaki (Kansai Medical University, Osaka, Japan) 
2.2 Cell culture 
Primary cultures of human vascular smooth muscle cells (VSMCs) were obtained from 
discarded sections of saphenous veins from patients undergoing surgery at the Alfred Hospital 
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(Melbourne, Australia) the acquisitions of the vessels was approved from the Alfred Hospital 
Ethics Committee. VSMCs were grown in DMEM (5mM glucose, 10% FBS and 1% antibiotics 
at 37°C in 5% CO2). VSMCs were seeded in 60 mm dishes and 6 well-plates. Cells were grown 
to confluence then rendered quiescent by serum deprivation for 48 h. Inhibitors were pre-
incubated for 30 min prior to treatment with agonists. Incubation times and concentrations are 
given in detail in the figure legends. 
2.3 Western blotting 
Whole cell lysates (30μg of protein) were resolved on 10% SDS-PAGE and semi-dry 
transferred onto PVDF. Membranes were blocked with 5% bovine serum albumin and 
incubated with primary antibody targeting protein of interest followed by HRP-anti-rabbit IgG 
and ECL detection. The protein of interest was normalised with GAPDH to determine equal 
loading. Blots were imaged using the Bio-Rad gel documentation system and densitometry 
analysis was performed with Quantity One imaging software. 
2.4 Assessing mRNA gene expression 
The mRNA level of the GAG enzymes was determined by quantitative real-time 
polymerase chain reaction (RT-PCR). Total RNA was isolated from VSMCs treated as 
described. RNA was extracted from 5×105 cells using RNeasy Mini kit (Qiagen) according to 
the manufacturers’ instructions. RNA purity was checked by spectrophotometry (260/280 nm) 
using Nanodrop2000 spectrophotometer (Thermo Fisher Scientific). First strand cDNA was 
synthesized from 1µg RNA using Quantitect reverse transcriptase kit (Qiagen) according to the 
manufacturers’ instructions. Quantitative RT-PCR was performed using Qiagen Rotor Gene Q 
and QuantiFast SYBR green PCR master mix kit (Qiagen). Data was normalised to the 
ribosomal 18S housekeeping gene to adjust for control variations between individual 
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experiments. Relative expression of mRNA levels was quantified using comparative ΔΔ Ct 
method. Experiments were performed in duplicate at least three times.  
2.5 Statistical analysis 
Normalised data is expressed as the mean ± standard error of the mean of three 
independent experiments, unless stated otherwise. A one-way ANOVA was used to calculate 
statistical significance of normalised data as stated followed by least significant difference 
post-hoc analysis. Results were considered significant when the probability was less than 0.05 
(*p<0.05) and 0.01 (**p<0.01). 
3. Results 
3.1 Thrombin stimulates the phosphorylation of individual Smad2 linker 
region residues in VSMCs 
There are at least four important phosphorylation sites on the human Smad2 linker region 
being Thr220, Ser245, Ser250 and Ser255 [3]. To determine whether site-specific linker region 
phosphorylation is mediated by thrombin signalling in VSMCs, a time course study was 
preformed with antibodies specific for the individual phosphorylated linker region residues 
[28]. Thrombin treated VSMCs showed a rapid increase in the phosphorylation of the Thr220 
residue. Thrombin mediated phosphorylation peaked at 15 min with a 2.5-fold (p<0.01) change 
when compared to basal (Figure 1A). Phosphorylation was sustained although there was a 
gradual decline over the 4h treatment. There was also a rapid increase in the phosphorylation 
of Ser245 reaching a peak of 1.9-fold (p<0.01) at 15 min when compared to basal (Figure 1B). 
This was sustained for 4h. Similarly the Ser250 residue was rapidly phosphorylated in the 
presence of thrombin with a peak phosphorylation of 2.5-fold (p<0.01) at 15 min (Figure 1C). 
The phosphorylation of this residue was sustained for 60 min. The phosphorylation of the 
Ser255 residue followed the same trend as the other linker region residues in which thrombin 
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caused a rapid increase with a peak at 15 min of 2.5-fold (p<0.01) when compared to basal and 
this gradually declined over 4h. These results demonstrate that in VSMCs thrombin treatment 
rapidly phosphorylates Thr220, Ser245, Ser250 and Ser255 in the Smad2 linker region. The 
challenge then is to determine the kinases mediating these specific phosphorylations.  
3.2 The involvement of serine/threonine kinases in thrombin stimulated 
phosphorylation of Smad2 linker region residues  
Smad2 linker region phosphorylation involves activation of serine/threonine kinases. 
Here we investigated kinases Erk, p38, Jnk, PI3K and CDK on thrombin phosphorylation of 
individual Smad2 linker region residues. VSMCs treated with thrombin for 30 min increased 
the phosphorylation of the Thr220 to 2.7-fold (p<0.01) (Figure 2A) which was unaffected in 
the presence of Erk and CDK inhibitors, UO126 and flavopiridol. Inhibitors to p38 and Jnk 
SB202190 and SP600124 partially inhibited thrombin mediated phosphorylation of Thr220 
and in the presence of PI3K inhibitor LY294002 this response was completely inhibited (Figure 
2A).These results demonstrate that phosphorylation of the Thr220 residue via thrombin 
dependent mechanisms involves p38, Jnk and PI3K pathways but not Erk and CDK. 
Thrombin treatment of VSMCs caused an increase in the phosphorylation of Ser245 to 
2-fold (p<0.01) at 30 min (Figure 2B). The presence of inhibitors to Erk, p38 and Jnk had no 
effect on the thrombin mediated phosphorylation of Ser245. PI3K inhibitor, partially inhibited 
thrombin mediated phosphorylation of Ser245, and in the presence of CDK inhibitor there was 
complete inhibition (p<0.01) (Figure 2B). Thus, thrombin stimulated Ser245 phosphorylation 
requires the activation of PI3K and CDK. 
In cells treated with thrombin, the level of the phosphorylation of Smad2 linker region 
residue Ser250 was increased to almost 3-fold (p<0.01) (Figures 2C). Erk inhibitor, UO126 
partialy inhibited Ser250 phosphorylation to 2-fold (p<0.05). In the presence of inhibitors to 
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p38, Jnk, PI3K and CDK the thrombin mediated phosphorylation of Ser250 is unnaffected 
(Figure 2C). Thus showing that Erk is the only kinase involved in thrombin mediated 
phosphorylation of Smad2 linker region residue Ser250. 
Thrombin mediated phosphoryaltion of the Ser255 residue was completely inhibited in 
the presence of UO126 (p<0.01) (Figure 2D). SB202190, LY294002 and flavopiridol partially 
inhbited this response however SP600125 had no effect (Figure 2D). Thus showing that 
thrombin mediated phosphorylation of Ser255 occurs via the activation of the Erk, p38, PI3K 
and CDK pathways. Taken together the results demonstrate that individual Smad2 linker region 
residues are phosphorylated by different serine/threonine kinases, with the PI3K being a 
common kinase for Thr220, Ser245 and Ser255 and Jnk is involved in regulating the Thr220 
residue. 
3.3 Thrombin stimulates the expression of genes associated with GAG 
initiation (XT-1) and elongation of CS GAG chains (C4ST-1 and CHSY-1)  
To investigate if thrombin can stimulate the mRNA expression of GAG biosynthesizing 
genes, specifically CHSY-1, C4ST-1 and XT-1, VSMCs were treated with thrombin (10 
units/ml) and the mRNA expression of these genes was measured over a 24 hour time period 
(Figure 3). During the biosynthesis of GAG chains, GalNAc residues of the repeating 
disaccharide units are sulfated at C4 by C4ST-1. Treatment of VSMCs with thrombin generated 
a parabolic time dependent increase in the mRNA expression of C4ST-1 (Figure 3A). At 2 
hours post thrombin treatment, a 1.4-fold increase (p<0.05) in the mRNA expression of C4ST-
1 was detected and reached a peak of 3-fold at 6-8 hours post stimulation (p<0.01) (Figure 3A). 
The addition of a monosaccharide to an acceptor oligosaccharide is referred to as chondroitin 
polymerization which occurs with the action of glycosyltransferase CHSY-1 [14]. Thrombin 
mediated mRNA expression of CHSY-1 followed a similar pattern to the expression of C4ST-
1 where it caused a parabolic time dependent increase in the mRNA expression (Figure 3B). 
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Thrombin treated VMSCs caused a 2-fold increase (p<0.05) in the mRNA expression of 
CHSY-1 at 4 hours and this was sustained reaching a peak of 3-fold (p<0.01) at 8 hours (Figure 
3B).  
 XT-1 is an enzyme that catalyses the attachment of xylose, the first residue of the 
linkage region that links the CS GAG chain backbone to proteoglycan core protein. When 
examining the mRNA expression of XT-1 we observed a slight increase of 1.8-fold (p<0.01) 
at 4 hours post treatment (Figure 3C). However from 4 hours onwards there was no effect on 
the mRNA expression of XT-1. Together these results demonstrate that thrombin treatment of 
VSMCs leads to an increase in the mRNA expression of GAG chain initiation gene XT-1 and 
GAG elongation genes C4ST-1 and CHSY-1.  
3.4 Thrombin stimulates the synthesis of C4ST-1 and CHSY1 proteins. 
The protein expression of C4ST-1 and CHSY-1 was measured using western blotting to 
investigate whether the increase in the mRNA expression resulted in the increase in the protein 
expression of the respective GAG synthesizing enzyme. Treatment with thrombin stimulated 
the synthesis of C4ST-1 from 16-24 h (Figure 4A). The peak protein expression of C4ST-1 of 
2-fold (p<0.01) was observed at 20 h. Thrombin treatment stimulated the expression of 
CHSY-1. An increase protein expression of CHSY-1 was observed from 16-24 h (p<0.01) 
(Figure 4B) with a peak of 2-fold reached at 20 h. Taken together these results demonstrate 
that the change in mRNA expression of C4ST-1 and CHSY-1 correlated with the protein 
expression of the respective enzymes.  
3.5 Thrombin regulates the mRNA expression of genes associated with the 
elongation of heparin sulphate GAG chains 
GAG chain synthesis requires the combined action of enzymes associated with polymerization 
and sulphation [29]. To investigate whether thrombin is involved in regulating the genes 
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associated with the elongation of heparin sulphate GAG chains the mRNA expression of 
extostatin-like glycosoltransferase (EXT)-1,2,3 and N-sulfotransferase-1 (NDST-1) was 
measured over an 8 hour time period (Figure 5). Treatment of VSMCs with thrombin generated 
a modest increase in the mRNA expression of EXT-1 to 1.5 fold (p<0.05)(Figure 5A) at 6 
hours. VSMCs treated with thrombin had no effect on the mRNA expression of EXT-2 (Figure 
5B). However thrombin treatment generated an increase in the mRNA expression of the EXT-3 
enzyme (Figure 5C). A gradual stimulation was observed at 2-hours, which reached a peak 
stimulation of 1.4-fold (p<0.01) (Figure 5C) at 6-8 hours with thrombin treatment. NDST-1 
involved in the sulphation of the heparin GAG chain was investigated. Treatment with 
thrombin over an 8 hour period had no effect on the mRNA levels of NDST-1. Taken toghether 
these results show that thrombin plays a modest role in regulating heparin sulphate synthezing 
enzymes EXT-1 and EXT-2 and is not involved in regulating EXT-2 and NDST-1 expression 
in VSMCs.  
 
3.6 Serine/threonine kinases differentially regulate thrombin mediated 
mRNA expression of genes involved in the initiation and elongation of 
GAG chains 
Our final aim was to evaluate the downstream consequences of Smad2 linker 
phosphorylation by measuring the expression of genes involved in GAG synthesis. Smad2 
linker region phosphorylation occurs via cytosolic serine/threonine kinases [25]. Hence, we 
hypothesized that the serine/threonine kinases involved in phosphorylation of the Smad2 linker 
region will regulate thrombin mediated mRNA expression of C4ST-1 and CHSY-1.  
VSMCs treated with thrombin for 6 hours showed a 2.9-fold increase in the mRNA 
expression of C4ST-1 compared to non-treated cells (Figure 6A). In the presence of UO126, 
SB202190, LY294002 and flavopiridol thrombin stimulated mRNA expression of C4ST-1 was 
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almost completely inhibited (Figure 6A). In the presence of the Jnk inhibitor SP600125 there 
was no inhibition of C4ST-1 mRNA expression. This data shows that Erk, p38, PI3K and CDK 
pathways are involved in thrombin stimulation of C4ST-1 mRNA expression. 
Thrombin treatment of VSMCs showed a 2-fold increase of CHSY-1 mRNA expression 
(Figures 6B). Thrombin mediated mRNA expression of CHSY-1 was inhibited in the presence 
of Erk, p38, PI3K and CDK inhibitors (Figure 6B). Thrombin stimulated CHSY-1 mRNA 
expression was not blocked by Jnk inhibitor, SP600125. These data demonstrate that thrombin 
stimulation of CHSY-1 mRNA expression involved Erk, p38, PI3K and CDK but not Jnk. The 
serine/threonine kinases involved in thrombin mediated mRNA expression of GAG enzymes 
C4ST-1 and CHSY-1 are the same for both genes. 
Thrombin mediated mRNA expression of C4ST-1 and CHSY-1 was not regulated by 
Jnk. We have previously demonstrated that Jnk, was not involved in TGF-β mediated 
proteoglycan synthesis and GAG elongation however its role in GAG chain initiation has not 
yet been investigated [20]. Our earlier results (Figure 2) showed that the Jnk inhibitor 
SP600125 has no effect on thrombin mediated phosphorylation of the serine residues 
(Ser245/250/255). However Jnk played a role in thrombin mediated phosphorylation of the 
Thr220 residue. Here we explored the role of the kinases which regulate the Thr220 residue 
and their role in the initiation of the GAG chain by studying mRNA expression of XT-1. 
VSMCs treated with thrombin showed a 3 fold increase in the mRNA expression of XT-1 
(Figure 6C). In the presence of SP600125, LY294002 and SB202190 thrombin mediated 
mRNA expression of XT-1 was inhibited by approximately 50 percent to 2 fold (Figure 6C). 
This data shows that the Jnk, PI3K and p38 are involved in thrombin mediated mRNA 
expression of XT-1 and GAG chain initiation demonstrating the exquisite specificity of the 
signalling pathways regulating the synthesis of a single molecule – biglycan. 
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4.  Discussion 
Proteoglycan core protein synthesis as well as the hyperelongation of GAG chain results 
in increased binding to LDL causing increased lipid retention and accelerated atherosclerosis 
[2, 30]. Signalling pathways regulating proteoglycan synthesis and GAG chain elongation have 
therapeutic potential as targets for early onset of atherosclerosis [31]. Thrombin signalling 
pathways leads to proteoglycan synthesis, GAG elongation [10] and an increase in the mRNA 
expression of GAG synthesizing genes [11]. TGF-β mediated proteoglycan synthesis [20, 32] 
and GAG gene expression [19, 21] are regulated by the phosphorylation of transcription factor 
Smad2 in the linker region. Multiple signalling pathways are involved in Smad2 linker region 
phosphorylation [3, 8]. In this study we investigated the role of the phosphorylation of 
individual Smad2 linker region residues in thrombin mediated expression of GAG synthesising 
genes involved in the initiation and elongation of GAG chains.   
The key findings of this study are that in VSMCs, treatment with thrombin can rapidly 
increase the phosphorylation of the 4 residues of the Smad2 transcription factors in its linker 
region. Thrombin treatment activated Erk, p38, PI3K and CDKs but not Jnk to mediate GAG 
chain hyperelongation measured as CHSY-1 and C4ST-1 mRNA expression. The same 
serine/threonine kinases activate the serine residues of the Smad2 linker region. Interestingly 
phosphorylation of the Thr220 residue and the mRNA expression of XT-1 were regulated by 
Jnk, p38 and PI3K, thus showing a correlation between the phosphorylation of the Thr220 and 
the initiation of GAG chain synthesis.  
In VSMCs, TGF-β mediated Smad2 linker region phosphorylation of the serine residues 
occurs via the activation of Erk and p38 but not Jnk [19, 20]. In our study thrombin 
phosphorylation of the serine residues required Erk and P38 but not Jnk. However a Jnk 
inhibitor abolished thrombin phosphorylation of theThr220 residue. Thrombin signals via 
transactivation of a protein tyrosine kinase and a serine/threonine kinase receptor [33]. In our 
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earlier work we have shown that thrombin mediated Smad2 linker region phosphorylation 
partially occurs via transactivation of the EGFR [11]. There have been a number of studies 
showing that tyrosine kinase receptor agonists activate the Jnk pathway, leading to the 
phosphorylation of the Smad2/3 linker region. Hepatocyte growth factor treated RGM-1 cells 
activated the Jnk pathway, inducing phosphorylation of Smad2 linker region [34]. PDGF 
treated rat hepatic stellate cells rapidly increase the phosphorylation of Smad2/3 threonine 
residue which was inhibited in the presence of a Jnk antagonist. In human keratinocytes Jnk 
had no effect on thrombin mediated phosphorylation of the serine residues of the Smad2 linker 
region [35]. However in a rat model of liver injury, activation of Jnk was accompanied by 
phosphorylation of Smad2 Ser249 and 254 [36]. This shows that Jnk activation of the threonine 
residue of the Smad linker region may be specific for PTKR signalling in VSMCs. 
The MAPK Erk regulated thrombin mediated phosphorylation of the Ser250 and Ser255 
residues. In AKR-2B [37] and NIH/373 fibroblasts [38] TGF-β mediated phosphorylation of 
Ser245/250/255 is dependent on Erk. In CD4+ T helper cells Erk drives the phosphorylation 
of only the Ser255 residue [39]. A study from our lab showed that in BAECs, TGF-β activation 
of Erk leads to the phosphorylation of Ser245, Ser250 and Ser255 [27]. In TGF-β mediated 
phosphorylation of the Smad2 linker region in human VSMCs, Erk was involved in the 
phosphorylation of Ser245, Ser250 and Ser255 residues but not the phosphorylation of the 
Thr220 [19]. Interestingly, the Thr220 residue was not regulated by TGF-β mediated Erk 
phosphorylation in both BAECs and VSMCs and in our current thrombin model. Thrombin 
mediated mRNA expression of the two GAG genes (C4ST-1 and CHSY-1) involved in the 
elongation of GAG chains was regulated by thrombin. Thus these results are in agreement with 
our previous work that Erk driven pathways are associated with proteoglycan synthesis and in 
driving the expression of GAG synthesising genes in VSMCs [19, 20]. 
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The present work identifies that thrombin phosphorylation of Ser245 and Ser255 is 
regulated by CDK. Similarly, in BAECs, CDK phosphorylates the Ser245 and Ser255 residues 
[27]. This shows that in these two cell models, CDK does not activate the Ser250 leading to 
PAI-1 expression or C4ST-1 and CHYS1 expression in VSMCs. Consistent with our results, 
CDK is not involved in the phosphorylation of the Thr220 residue in a melanoma model [40]. 
Direct activation of the TGFBR1 in VMSCs reveals that CDK is only involved in the 
phosphorylation of the Thr220 residue of the Smad2 linker region [19, 21]. Interestingly, unlike 
the model proposed by our own data, TGF-β stimulation of CDK family members has a greater 
incidence for the phosphorylation of the Thr220 than the serine residues [41-43]. PI3K could 
act as an upstream mediator for CDK activation [44]. Thrombin mediated phosphorylation of 
the Smad2 linker region residues Ser245 and Ser255 occurs via PI3K and CDK however 
Thr220 is only dependent on PI3K activation. PI3K was also shown to participate in thrombin 
mediated mRNA expression of C4ST-1, CHSY-1 and XT-1. PDGF and thrombin are known 
to activate PI3K via Akt [45]. Data from our lab (unpublished) shows that PI3K is partially 
involved in thrombin mediated proteoglycan synthesis. VSMCs treated with thrombin 
increased the phosphorylation of the serine residues of Smad2 linker region, this was 
unaffected by Akt inhibitor [45]. These results demonstrate that, in VSMCs, thrombin 
regulation of the Smad2 linker serine residues does not involve the PI3K/Akt signalling but 
instead requires the PI3K/CDK pathways, correlating with the results showing that thrombin 
mediated linker region phosphorylation does not involve Akt [45].  
Thrombin mediated mRNA expression of C4ST-1 and CHSY-1 occurs via 
transactivation of TGFBR1 and the EGFR [11]. The mRNA expression of the GAG 
synthesizing enzymes correlates with proteoglycan synthesis and GAG elongation [46]. TGF-
β mediated GAG chain elongation is associated with Smad2 linker region phosphorylation. 
The CHSY-1 enzyme is directly involved in addition of repeated monosaccharide units on 
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GAG chains, the sulfation enzymes C4ST-1 is involved in the sulfation of the GAG chain to 
provide docking sites for the addition of disaccharide units [47]. Thrombin can activate Erk, 
p38, PI3K and CDK to stimulate an increase in the mRNA expression of C4ST-1 and CHSY-
1. Among the MAPKs involved in TGF-β signalling in VSMCs, Erk and p38 but not Jnk have 
been identified to modify GAG chains. In nucleus pulposus cells of invertebral discs, Erk 
participates in TGF-β regulation of CHSY-1 expression [48]. The data presented in this study 
is consistent with these two models.  
Jnk did not regulate TGF-β mediated GAG gene [49] and GAG chain hyperelongation 
[20] in VSMCs. Thrombin phosphorylation of the Thr220 residue is regulated by Jnk, PI3K 
and p38. Interestingly thrombin mediated expression of the rate limiting genes involved in the 
elongation of GAG chains is not regulated by Jnk, however, the mRNA expression of the 
enzyme involved in the initiation of the GAG chains is regulated by Jnk, PI3K and p38. TGF-
β mediated phosphorylation of the Smad2 Thr220 residue regulates XT-1 mRNA expression 
[19]. Knock down of XT-1 mRNA reduced GAG chain synthesis in cardiac fibroblasts [50]. 
Akt phosphorylation had no effect on TGF-β mediated GAG chain elongation however it 
played a role in proteoglycan synthesis [45]. In the current model of thrombin mediated GAG 
chain elongation as measured by the increase in the mRNA expression of C4ST-1 and CHSY-
1, the PI3K/CDK not the PI3K/Akt pathway regulates GAG chain elongation, however the 
phosphorylation of the Thr220 residue was unaffected in presence of CDK inhibitor thus the 
Thr220 requires the activation of PI3K/Akt. Taken together the data indicates that 
phosphorylation of Thr220 residue regulates the expression of XT-1 gene.  
5. Conclusions: 
We have shown that PAR-1 mediated mRNA expression of two GAG synthesizing genes 
associated with the elongation of GAG chains on biglycan correlated with the phosphorylation 
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of the Smad2 linker region. However, PAR-1 mediated initiation GAG chain synthesis, as 
measured by the mRNA expression of XT-1, correlates to the phosphorylation of Thr220. 
Thrombin mediated GAG chain elongation requires pathways which activate Erk, p38 and 
PI3K/CDK but not Jnk, however the initiation of GAG chains require Jnk activation. These 
findings represent an example and a model of a concurrent signalling cascade which may 
provide a therapeutic target for human diseases, such as atherosclerosis, glomerulosclerosis 
and age related macular degeneration which have the underlying mechanism of lipid binding 
and entrapment by modified chondroitin sulfate/ dermatan sulfate proteoglycans.  
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Figure 1: Time course of thrombin mediated phosphorylation of four specific Smad2 
linker region residues. Western blots probed with antibodies specific to A phospho-
Smad2/3(Thr220/179) B phospho-Smad2(Ser245) C anti-phospho-Smad2(Ser250) and D anti-
phospho-Smad2(Ser255). Blots shown are representative of three independent experiments. 
Histograms represent band density expressed as fold per basal from three independent 
experiments (*p<0.05 vs basal) (**p<0.01 vs basal) using one-way ANOVA followed by least 
significant difference post-hoc analysis.  
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Figure 2: Effects of inhibitors to Erk, p38, Jnk, CDK and PI3K on thrombin mediated 
Smad2 linker phosphorylation via the transactivation of the EGFR. VSMCs were treated 
with thrombin for 15 min in the presence and absence of each of the serine/threonine kinase 
inhibitors. Each blot was probed with antibodies specific to A. phospho-Smad2/3(Thr220/179) 
B. phospho-Smad2(Ser245) C. phospho-Smad2(Ser250) and D. phospho-Smad2(Ser255). 
Blots are representative of three-independent experiments. Histogram represents band density 
expressed as fold per basal. Statistical significance was determined by one-way ANOVA, 
followed by least significant difference post-hoc analysis ##,p<0.01 versus basal and **, 
p<0.01 agonist versus antagonist.  
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Figure 3: Time course of thrombin mediated mRNA expression of GAG synthesizing 
genes C4ST-1, CHSY-1 and XT-1. VSMCs were treated with thrombin (10units/ml) to 
investigate the effect of the mRNA expression of A C4ST-1, B CHSY-1 and C XT-1. Total 
RNA was harvested, cDNA was synthesized and the mRNA expression of these genes was 
analysed using quantitative RT-PCR. 18S was used as a house keeping gene. Results are 
expressed as the mean ± standard error from three independent experiments. Statistical 
significance was determined by one-way ANOVA, followed by the least significance post hoc 
analysis, **p<0.01 and * p<0.05 basal versus agonist. 
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Figure 4: Thrombin time course of GAG synthesizing enzyme C4ST-1 and CHSY-1 
protein expression. VSMCs were treated with thrombin (10 units/ml) for 16, 18, 20 and 24 
hr. Western blots probed with antibodies specific to A C4ST-1 and B CHSY-1. Blots shown 
are representative of three independent experiments. Histograms represent band density 
expressed as fold per basal. Statistical significance was determined by one-way ANOVA 
followed by least significant difference post-hoc analysis ** p<0.01 versus non treated basal.  
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Figure 5: Time course of thrombin mediated mRNA expression of heparin sulfate 
synthesizing genes EXT1, EXT2, EXT3 and NDST1. VSMCs were treated with thrombin 
(10units/ml) to investigate the effect of the mRNA expression of A EXT1, B EXT2, C EXT3 
and D NDST1. Total RNA was harvested, cDNA was synthesized and the mRNA expression 
of these genes was analysed using quantitative RT-PCR. 18S was used as a house keeping 
gene. Results are expressed as the mean ± standard error from three independent experiments. 
Statistical significance was determined by one-way ANOVA, followed by the least 
significance post hoc analysis, **p<0.01 and * p<0.05 basal versus agonist. 
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Figure 6: Serine/threonine kinases differentially regulate thrombin mediated mRNA 
expression of GAG synthesizing enzymes. VSMCs were pre-treated with serine/threonine 
kinase inhibitors in the presence of thrombin to determine the effects on the mRNA expression 
of A. C4ST-1, B. CHSY-1 and C. XT-1. Data are expressed as the mean ± standard error from 
three experiments. Statistical significance was determined by one-way ANOVA, followed by 
least significant difference post-hoc analysis. ##,p<0.01 basal versus thrombin and *,p<0.01 
and **,p<0.01 thrombin versus antagonist was used for statistical analysis. 
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Highlights 
 Thrombin stimulates Smad linker region phosphorylation 
 Thrombin stimulates the expression of glycosaminoglycan synthesising genes 
 Serine residues of Smad linker region correlated with GAG chain elongation 
 Threonine residue of Smad linker region correlated with GAG chain initiation  
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